Submitted by mike kraft on
Though 33 states now have face mask mandates, Gov. Pete Ricketts says his state of Nebraska will not be joining them. On Monday, Ricketts doubled down on his conviction that a statewide mask mandate would be too “heavy-handed.”
Submitted by mike kraft on
U.S. testing for the coronavirus is dropping even as infections remain high and the death toll rises by more than 1,000 a day, a worrisome trend that officials attribute largely to Americans getting discouraged over having to wait hours to get a test and days or weeks to learn the results.
Submitted by mike kraft on
Submitted by mike kraft on
So far, most of the conversation about COVID-19 vaccines has focused on the question of whether researchers can develop an effective vaccine in record time.
But maybe we should start asking another question as well: Will enough Americans actually get the vaccine for it to be effective?
“It’s not a vaccine that will save us,” says Harvard Global Health Institute director Ashish Jha. “It’s vaccination.”
Submitted by mike kraft on
The soaring number of COVID-19 cases in the United States has far outstripped many local health departments’ ability to trace the contacts of those infected, a step critical in containing the virus’ spread.
Submitted by mike kraft on
WASHINGTON (AP) — The Trump administration’s plan to provide every nursing home with a fast COVID-19 testing machine comes with an asterisk: The government won’t supply enough test kits to check staff and residents beyond an initial couple of rounds.
Submitted by mike kraft on
Submitted by mike kraft on
An experimental coronavirus vaccine developed by Johnson & Johnson protected monkeys from infection in a new study. It is the second vaccine candidate to show promising results in monkeys this week.
The company recently began a clinical trial in Europe and the United States to test its vaccine in people. It is one of more than 30 human trials for coronavirus vaccines underway across the world. But until these trials are complete — which will probably take several months — the monkey data offers the best clues to whether the vaccines will work.
Submitted by mike kraft on
In April, with hospitals overwhelmed and much of the United States in lockdown, the Department of Health and Human Services produced a presentation for the White House arguing that rapid development of a coronavirus vaccine was the best hope to control the pandemic.
“DEADLINE: Enable broad access to the public by October 2020,” the first slide read, with the date in bold.
Submitted by mike kraft on
Deborah Birx said Sunday that the COVID-19 outbreak is not under control in the U.S. because Americans "are on the move."
/cdn.vox-cdn.com/uploads/chorus_asset/file/21696249/GettyImages_1254338202__1_.jpg)
